Mark L. Berch

Array ( [id] => 7169443 [patent_doc_number] => 20040077645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Xanthine derivatives,production and use thereof as medicament' [patent_app_type] => new [patent_app_number] => 10/467961 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73925 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077645.pdf [firstpage_image] =>[orig_patent_app_number] => 10467961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288140 [patent_doc_number] => 20040147502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Beta lactam compounds and their use as inhibitors of tryptase' [patent_app_type] => new [patent_app_number] => 10/728276 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17642 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147502.pdf [firstpage_image] =>[orig_patent_app_number] => 10728276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314877 [patent_doc_number] => 07524847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Fused 1,3-dihydro-imidazole ring compounds' [patent_app_type] => utility [patent_app_number] => 10/537227 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31385 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524847.pdf [firstpage_image] =>[orig_patent_app_number] => 10537227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721460 [patent_doc_number] => 20060074236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Crystalline cefdinir salts' [patent_app_type] => utility [patent_app_number] => 10/539122 [patent_app_country] => US [patent_app_date] => 2003-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1862 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074236.pdf [firstpage_image] =>[orig_patent_app_number] => 10539122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 638038 [patent_doc_number] => 07125993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'A2B adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/719102 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20791 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125993.pdf [firstpage_image] =>[orig_patent_app_number] => 10719102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410222 [patent_doc_number] => 20040176350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Carbapenem compound' [patent_app_type] => new [patent_app_number] => 10/478423 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5523 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176350.pdf [firstpage_image] =>[orig_patent_app_number] => 10478423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739248 [patent_doc_number] => 20060009639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Process for the preparation of cefpodoxime proxetil' [patent_app_type] => utility [patent_app_number] => 10/535923 [patent_app_country] => US [patent_app_date] => 2003-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2094 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009639.pdf [firstpage_image] =>[orig_patent_app_number] => 10535923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274286 [patent_doc_number] => 07560450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/716141 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14969 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560450.pdf [firstpage_image] =>[orig_patent_app_number] => 10716141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739051 [patent_doc_number] => 20060009442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Process for producing carbapenem compound for oral administration' [patent_app_type] => utility [patent_app_number] => 10/533183 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5708 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009442.pdf [firstpage_image] =>[orig_patent_app_number] => 10533183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662333 [patent_doc_number] => 20060252929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Novel intermediate for carbapenem compound for oral administration and process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/533868 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7280 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252929.pdf [firstpage_image] =>[orig_patent_app_number] => 10533868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002541 [patent_doc_number] => 06908996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Compounds and method for preparing 3-methylcephams' [patent_app_type] => utility [patent_app_number] => 10/706683 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6290 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908996.pdf [firstpage_image] =>[orig_patent_app_number] => 10706683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7336986 [patent_doc_number] => 20040132709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates' [patent_app_type] => new [patent_app_number] => 10/706768 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14916 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132709.pdf [firstpage_image] =>[orig_patent_app_number] => 10706768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7238475 [patent_doc_number] => 20040157793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Modified nucleosides as antiviral agents' [patent_app_type] => new [patent_app_number] => 10/706865 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9409 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157793.pdf [firstpage_image] =>[orig_patent_app_number] => 10706865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821071 [patent_doc_number] => 20060025384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'New crystal form of adefovir dipivoxil and its composition' [patent_app_type] => utility [patent_app_number] => 10/534602 [patent_app_country] => US [patent_app_date] => 2003-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6835 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025384.pdf [firstpage_image] =>[orig_patent_app_number] => 10534602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808348 [patent_doc_number] => 20060094703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Novel amorphous hydrate of a cephalosporin antibiotic' [patent_app_type] => utility [patent_app_number] => 10/532753 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3751 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094703.pdf [firstpage_image] =>[orig_patent_app_number] => 10532753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7338227 [patent_doc_number] => 20040132995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Process for the preparation of cephalosporins' [patent_app_type] => new [patent_app_number] => 10/700679 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3532 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132995.pdf [firstpage_image] =>[orig_patent_app_number] => 10700679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656838 [patent_doc_number] => 20060142574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Process for the preparation of ganciclovir' [patent_app_type] => utility [patent_app_number] => 10/532910 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2060 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142574.pdf [firstpage_image] =>[orig_patent_app_number] => 10532910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 634175 [patent_doc_number] => 07129232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Cephem compounds' [patent_app_type] => utility [patent_app_number] => 10/695895 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39203 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129232.pdf [firstpage_image] =>[orig_patent_app_number] => 10695895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 363525 [patent_doc_number] => 07482337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/695597 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21004 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/482/07482337.pdf [firstpage_image] =>[orig_patent_app_number] => 10695597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 330639 [patent_doc_number] => 07511135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Method for manufacture of ceftiofur' [patent_app_type] => utility [patent_app_number] => 10/532194 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6777 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/511/07511135.pdf [firstpage_image] =>[orig_patent_app_number] => 10532194 [rel_patent_id] =>[rel_patent_doc_number] =>)